These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 25827529)

  • 1. Mucosal vaccination by adenoviruses displaying reovirus sigma 1.
    Weaver EA; Camacho ZT; Hillestad ML; Crosby CM; Turner MA; Guenzel AJ; Fadel HJ; Mercier GT; Barry MA
    Virology; 2015 Aug; 482():60-6. PubMed ID: 25827529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a Fiber-Modified Adenovirus Vector Vaccine against Foot-and-Mouth Disease in Cattle.
    Medina GN; Montiel N; Diaz-San Segundo F; Sturza D; Ramirez-Medina E; Grubman MJ; de los Santos T
    Clin Vaccine Immunol; 2015 Nov; 23(2):125-36. PubMed ID: 26607309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Capsid display of a conserved human papillomavirus L2 peptide in the adenovirus 5 hexon protein: a candidate prophylactic hpv vaccine approach.
    Wu WH; Alkutkar T; Karanam B; Roden RB; Ketner G; Ibeanu OA
    Virol J; 2015 Sep; 12():140. PubMed ID: 26362430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mosaic fiber adenovirus serotype 5 vector containing reovirus sigma 1 and adenovirus serotype 3 knob fibers increases transduction in an ovarian cancer ex vivo system via a coxsackie and adenovirus receptor-independent pathway.
    Tsuruta Y; Pereboeva L; Glasgow JN; Rein DT; Kawakami Y; Alvarez RD; Rocconi RP; Siegal GP; Dent P; Fisher PB; Curiel DT
    Clin Cancer Res; 2007 May; 13(9):2777-83. PubMed ID: 17473211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction and characterization of a recombinant human adenovirus type 3 vector containing two foreign neutralizing epitopes in hexon.
    Xue C; Tian X; Li X; Zhou Z; Su X; Zhou R
    Virus Res; 2014 Apr; 183():67-74. PubMed ID: 24518297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-cell-biased immune responses generated by a mucosally targeted adenovirus-σ1 vaccine.
    Weaver EA; Mercier GT; Gottschalk S; Barry MA
    Mucosal Immunol; 2012 May; 5(3):311-9. PubMed ID: 22377931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yeast Surface Display of Capsid Protein VP7 of Grass Carp Reovirus: Fundamental Investigation for the Development of Vaccine Against Hemorrhagic Disease.
    Luo S; Yan L; Zhang X; Yuan L; Fang Q; Zhang YA; Dai H
    J Microbiol Biotechnol; 2015 Dec; 25(12):2135-45. PubMed ID: 26282690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant influenza virus carrying human adenovirus epitopes elicits protective immunity in mice.
    Yang P; Li T; Liu N; Gu H; Han L; Zhang P; Li Z; Wang Z; Zhang S; Wang X
    Antiviral Res; 2015 Sep; 121():145-51. PubMed ID: 26112646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased efficacy of an adenovirus-vectored foot-and-mouth disease capsid subunit vaccine expressing nonstructural protein 2B is associated with a specific T cell response.
    Moraes MP; Segundo FD; Dias CC; Pena L; Grubman MJ
    Vaccine; 2011 Nov; 29(51):9431-40. PubMed ID: 22027486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the adenovirus hexon protein.
    Sumida SM; Truitt DM; Lemckert AA; Vogels R; Custers JH; Addo MM; Lockman S; Peter T; Peyerl FW; Kishko MG; Jackson SS; Gorgone DA; Lifton MA; Essex M; Walker BD; Goudsmit J; Havenga MJ; Barouch DH
    J Immunol; 2005 Jun; 174(11):7179-85. PubMed ID: 15905562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective Efficacy in Sheep of Adenovirus-Vectored Vaccines against Bluetongue Virus Is Associated with Specific T Cell Responses.
    Martín V; Pascual E; Avia M; Peña L; Valcárcel F; Sevilla N
    PLoS One; 2015; 10(11):e0143273. PubMed ID: 26619062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single dose adenovirus vectored vaccine induces a potent and long-lasting immune response against rabbit hemorrhagic disease virus after parenteral or mucosal administration.
    Fernández E; Toledo JR; Chiong M; Parra F; Rodríguez E; Montero C; Méndez L; Capucci L; Farnós O
    Vet Immunol Immunopathol; 2011 Aug; 142(3-4):179-88. PubMed ID: 21621855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Avian reovirus sigma C enhances the mucosal and systemic immune responses elicited by antigen-conjugated lactic acid bacteria.
    Lin KH; Hsu AP; Shien JH; Chang TJ; Liao JW; Chen JR; Lin CF; Hsu WL
    Vaccine; 2012 Jul; 30(33):5019-29. PubMed ID: 22531554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenovirus-vectored type Asia1 foot-and-mouth disease virus (FMDV) capsid proteins as a vehicle to display a conserved, neutralising epitope of type O FMDV.
    Chai Z; Wang H; Zhou G; Yang D; Wang J; Yu L
    J Virol Methods; 2013 Mar; 188(1-2):175-82. PubMed ID: 22981982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification of Ad5 hexon hypervariable regions circumvents pre-existing Ad5 neutralizing antibodies and induces protective immune responses.
    Bruder JT; Semenova E; Chen P; Limbach K; Patterson NB; Stefaniak ME; Konovalova S; Thomas C; Hamilton M; King CR; Richie TL; Doolan DL
    PLoS One; 2012; 7(4):e33920. PubMed ID: 22496772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of shielding adenoviral vectors with polyethylene glycol on vector-specific and vaccine-mediated immune responses.
    Weaver EA; Barry MA
    Hum Gene Ther; 2008 Dec; 19(12):1369-82. PubMed ID: 18778197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal administration of a recombinant adenovirus expressing the norovirus capsid protein stimulates specific humoral, mucosal, and cellular immune responses in mice.
    Guo L; Wang J; Zhou H; Si H; Wang M; Song J; Han B; Shu Y; Ren L; Qu J; Hung T
    Vaccine; 2008 Jan; 26(4):460-8. PubMed ID: 18160189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amplified and persistent immune responses generated by single-cycle replicating adenovirus vaccines.
    Crosby CM; Nehete P; Sastry KJ; Barry MA
    J Virol; 2015 Jan; 89(1):669-75. PubMed ID: 25355873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient intranasal immunization of newborn mice with recombinant adenovirus expressing rotavirus protein VP4 against oral rotavirus infection.
    Liu X; Yang T; Sun QM; Sun MS
    Acta Virol; 2005; 49(1):17-22. PubMed ID: 15929394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete protection of mice against a lethal dose challenge of western equine encephalitis virus after immunization with an adenovirus-vectored vaccine.
    Wu JQ; Barabé ND; Chau D; Wong C; Rayner GR; Hu WG; Nagata LP
    Vaccine; 2007 May; 25(22):4368-75. PubMed ID: 17467858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.